NCT06750159 2024-12-27
The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma
Peking Union Medical College Hospital
Not yet recruiting
Clinical Trials
7 trialsNCT06637059 2024-10-15
Artificially Intelligent Model for Accurate Detection of HCC
Zhejiang University
Completed
NCT02109146 2024-05-29
Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma
Zhejiang University
Phase 3 Completed
NCT05292443 2024-02-23
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
Geneplus-Beijing Co. Ltd.
Withdrawn
NCT05661786 2022-12-22
PILOT
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Recruiting
NCT00759109 2017-04-07
Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT00767234 2016-07-11
Permission to Collect Blood Over Time for Research
Stanford University
Terminated